These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19606929)

  • 1. Primary liver tumors: origin and target therapy.
    Papoulas M; Theocharis S
    Expert Opin Ther Targets; 2009 Aug; 13(8):957-65. PubMed ID: 19606929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
    Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
    Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK; Castilho A; Ma S; Ng IO
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cancer: a disease of stem cells?
    Alison MR
    Panminerva Med; 2006 Sep; 48(3):165-74. PubMed ID: 17122752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
    Chiba T; Kamiya A; Yokosuka O; Iwama A
    Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic progenitor cells in human liver tumor development.
    Libbrecht L
    World J Gastroenterol; 2006 Oct; 12(39):6261-5. PubMed ID: 17072946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis.
    Heim D; Wege H
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):111-21. PubMed ID: 19305371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of hepatocellular carcinoma: role of stem cells.
    Wu XZ; Chen D
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1093-8. PubMed ID: 16824058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of contactin associated protein-like 2 in a subset of hepatic progenitor cell compartment identified by gene expression profiling in hepatitis B virus-positive cirrhosis.
    Wang H; Gao Y; Jin X; Xiao J
    Liver Int; 2010 Jan; 30(1):126-38. PubMed ID: 19889080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
    Roskams T
    Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.
    Roh MS; Jeong JS; Kim YH; Kim MC; Hong SH
    Hepatogastroenterology; 2004; 51(59):1315-8. PubMed ID: 15362741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
    Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human hepatocellular carcinoma: expression profiles-based molecular interpretations and clinical applications.
    Hui KM
    Cancer Lett; 2009 Dec; 286(1):96-102. PubMed ID: 19095350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined hepato-cholangiocarcinoma. Case presentation and literature review].
    Salas AA; González AL; Goepfert RH
    Rev Gastroenterol Mex; 2006; 71(4):483-6. PubMed ID: 17542282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
    Ward SC; Waxman S
    Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cells: the source of hepatocellular carcinoma?
    Wu XZ; Yu XH
    Med Hypotheses; 2007; 69(1):36-42. PubMed ID: 17300877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrins as differential cell lineage markers of primary liver tumors.
    Volpes R; van den Oord JJ; Desmet VJ
    Am J Pathol; 1993 May; 142(5):1483-92. PubMed ID: 7684197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.